Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the Beta-3 adrenergic receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 2, 1998, Pages 720-724

  Fletcher, Daniel S ^a   Candelore, Mari Rios ^a   Grujic, Danica ^a,b   Lowell, Bradford B ^a,b   Luell, Silvi ^a   Susulic, Vedrana S ^a,c   Macintyre, D Euan ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID METHYL ESTER; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ADENYLATE CYCLASE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CHARCOAL; CLONIDINE; GLYCEROL; ICI 198157; ISOPRENALINE; SR 56811A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; GASTROINTESTINAL TRANSIT; GLYCEROL BLOOD LEVEL; INTESTINE TRANSIT TIME; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REGULATORY MECHANISM; STOMACH MOTILITY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; CLONIDINE; GASTROINTESTINAL TRANSIT; GLYCEROL; MICE; MICE, KNOCKOUT; PHENETHYLAMINES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0032464928     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Arch JRS, Ainsworth AT, Cawthorne VP, Sennitt MV, Thody VE, Wilson C and Wilson S (1984) Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163-165.
2. 3 and atypical β-adrenoceptors. Med Res Rev 13:663-729.
3. Bensaid M, Kaghad M, Rodriguez M, Le Fur G and Caput D (1993) The rat beta 3-adrenergic receptor gene contains an intron. FEBS Lett 318:223-226.
4. 3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289:223-228.
5. Bond RA and Clarke DE (1988) Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α- and β- subtypes. Br J Pharmacol 93:723-734.
6. Candelore MR, Deng L, Tota LM, Kelly LJ, Cascieri MA and Strader CD (1996) Pharmacological characterization of a recently described human β3-adrenergic receptor mutant. Endocrinology 137:2638-2641.
7. Chang F-Y, Lee S-D, Yeh G-H and Wang P-S (1995) Hyperglycaemia is responsible for the inhibited gastrointestinal transit in the early diabetic rat. Acta Physiol Scand 155:457-462.
8. 3 receptor? J Pharmacol Exp Ther 272:446-451.
9. Collins S, Daniel KW, Rohlfs EM, Ramkumar V, Taylor IL and Gettys TW (1994) Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8:518-527.
10. Croci T, Cecchi R, Tarantino A, Aureggi G, Bianchetti A, Boigegrain R and Manara L (1988) Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents. Pharmacol Res Commun 20:147-151.
11. Croci T, Giudice A, Bianchetti A and Manara L (1991) Colonic and cardiovascular actions of the atypical β-adrenergic agonist SR 58611A in rats. J Gastrointest Motil 3:273-279.
12. de Boer REP, Brouwer F and Zaagsma J (1995) Noradrenaline-induced relaxation of rat oesophageal muscularis mucosae: mediation solely by innervated β3-adrenoceptors. Br J Pharmacol 116:1945-1947.
13. De Ponti F, Cosentino M, Costa A, Girani M, Gibelli G, D'Angelo L, Frigo G and Crema A (1995) Inhibitory effects of SR 58611A on canine colonie motility: Evidence for a role of β3-adrenoceptors. Br J Pharmacol 114:1447-1453.
14. De Ponti F, Giaroni C, Cosentino M, Lecchini S and Frigo G (1996) Adrenergic mechanisms in the control of gastrointestinal motility: From basic science to clinical applications. Pharmacol Ther 69:59-78.
15. Eliasson B, Bjornsson E, Urbanavicius V, Andersson H, Fowelin J, Attvall S, Abrahamsson H and Smith U (1995) Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption. Diabetologia 38:79-85.
16. Emorine LJ, Marullo S, Briend-Sutren M-M, Patey G, Tate K, Delavier-Klutchko C and Strosberg AD (1989) Molecular characterization of the human beta 3-adrenergic receptor. Science 245:1118-1121.
17. 3-adrenoceptor mRNA in rat tissues. Br J Pharmacol 117:210-216.
18. 3-adrenergic receptor. Mol Pharmacol 40:895-899.
19. Giudice A, Croci T, Bianchetti A and Manara L (1989) Inhibition of rat colon motility and cardiovascular effects of new gut-specific beta-adrenergic phenylethanolamino-tetralines. Life Sci 44:1411-1417.
20. Grujic D, Susulic VS, Harper M-E, Jimms-Hagen J, Cunningham BA, Corkey BE, Flier JS and Lowell BB (1997) β3-adrenergic receptors in white and brown adipocytes mediate β3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem 272:17686-17693.
21. 3-adrenergic agonists of brown adipose tissue and thermogenesis. 1. [4-[2-[(2-hydroxy-3-phenoxvpropyl)amino]-ethoxy]phenoxy]acetates. J Med Chem 35:1751-1759.
22. Lafontan M and Berlan M (1993) Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34:1057-1091.
23. Landi M, Croci T and Manara L (1993) Similar atypical β-andrenergic receptors mediate in vitro rat adipocyte lipolysis and colonic motility inhibition. Life Sci 53:297-302.
24. Lezama EJ, Konkar AA, Salazar-Bookaman MM, Miller DD and Feller DR (1996) Pharmacological study of atypical β-adrenoceptors in rat esophageal smooth muscle. Eur J Pharmacol 308:69-80.
25. 3-adrenoceptors and intestinal motility. Fund Clin Pharmacol 9:332-342.
26. Manara L, Badone D, Baroni M, Boccardi G, Cecchi R, Croci T, Giudice A, Guzzi U, Landi M and LeFur G (1996) Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins. Br J Pharmacol 117:435-442.
27. Maugeri S, Ferre JP, Intorre L and Soldani G (1994) Effects of medetomidine on intestinal and colonie motility in the dog. J Vet Pharmacol Ther 17:148-154.
28. Miller MS, Galligan JJ and Burks TF (1961) Accurate measurement of intestinal transit in the rat. J Pharmacol Methods 6:211-217.
29. Muzzin P, Revelli J-P, Kuhne F, Gocayne JD, McCombie WR, Venter JC, Giacobino J-P and Frazer CM (1991) An adipose tissue-specific β-adrenergic receptor. J Biol Chem 266:24053-24058.
30. Nahmias C, Blin N, Elalouf J-M, Mattei MG, Strosberg AD and Emorine LJ (1991) Molecular characterization of the mouse β3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J 10:3721-3727.
31. Puig MM, Pol O and Warner W (1996) Interaction of morphine and clonidine on gastrointestinal transit in mice. Br J Anesthesia 76:A257.
32. Spiegelman BM and Flier JS (1996) Adipogenesis and obesity: rounding out the big picture. Cell 87:377-389.
33. 3-adrenergic receptor gene. J Biol Chem 270:29483-29492.
34. 3 subtypes. Neurogastroenterol Motil 8:143-151.
35. van der Vliet A, Rademaker B and Bast A (1990) A beta adrenoceptor with atypical characteristics is involved in the relaxation of the rat small intestine. J Pharmacol Exp Ther 255:218-255.
36. 3-adrenoceptor agonist, on sympathetic nervous system activity in mice. Metabolism 45:787-791.